Health and Fitness Health and Fitness
Mon, October 17, 2011
[ Mon, Oct 17th 2011 ] - Market Wire
Healthways Takes Its Commitment to Well-Being on .. nual Overnight Ragnar Relay Tennessee Partnership
[ Mon, Oct 17th 2011 ] - Market Wire
Leisureworld Announces October Dividend
[ Mon, Oct 17th 2011 ] - Market Wire
Medtronic Announces 510(k) Clearance for the Aqua .. ined Hemostatic Sealing and Cutting Functionality
[ Mon, Oct 17th 2011 ] - Market Wire
PharmStar Outstanding Common Stock Reduced by 50%
[ Mon, Oct 17th 2011 ] - Market Wire
AdCare Health Systems to Acquire Five Skilled Nursing Facilities in Oklahoma
[ Mon, Oct 17th 2011 ] - Market Wire
DMRJ Amends Implant Sciences' Credit Facility
[ Mon, Oct 17th 2011 ] - Market Wire
Marina Biotech, Inc. Announces a $15 Million Purc .. ase Agreement With Lincoln Park Capital Fund, LLC
[ Mon, Oct 17th 2011 ] - Market Wire
Lpath Initiates Dosing of iSONEP in Second of Two Proof-of-Concept Trials
[ Mon, Oct 17th 2011 ] - Market Wire
Immunovaccine Appoints Wayne Pisano to its Board
[ Mon, Oct 17th 2011 ] - Market Wire
Cellceutix Confident as Cancer Compound Shows Activity in All Cancers Tested
[ Mon, Oct 17th 2011 ] - Market Wire
Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer
[ Mon, Oct 17th 2011 ] - Market Wire
CytoSorbents Corporation Launches HemoDefend Puri .. for Blood Transfusion Applications at the AABB Co
Sun, October 16, 2011
[ Sun, Oct 16th 2011 ] - Market Wire
China Medical Technologies Announces the Approval .. Technology Enterprise Status for a Major Subsidia
Sat, October 15, 2011
[ Sat, Oct 15th 2011 ] - Market Wire
The Medicines Company's MDCO-2010 Meets Clinical .. ectives in Patients Undergoing Open-Heart Surgery
Fri, October 14, 2011
[ Fri, Oct 14th 2011 ] - Market Wire
Newly Published Study Highlights Systemic Growth .. g" Market;; DRM Ventures (DRM) and Patient
[ Fri, Oct 14th 2011 ] - Market Wire
Sangamo BioSciences Announces Presentation at the .. ual Newsmakers in the Biotech Industry Conference
[ Fri, Oct 14th 2011 ] - Market Wire
Par Pharmaceutical Files Declaratory Judgment to .. s to Disseminate Truthful Information Regarding M
[ Fri, Oct 14th 2011 ] - Market Wire
MannKind to Present at The 18th Annual Newsmakers in the BioTech Industry Conference
[ Fri, Oct 14th 2011 ] - Market Wire
Amarillo Biosciences Issues Corporate Update
[ Fri, Oct 14th 2011 ] - Market Wire
Enzo Reports Record Revenues of $102 Million for Fiscal Year 2011
[ Fri, Oct 14th 2011 ] - Market Wire
Greatbatch, Inc. Elects Anthony P. Bihl III to its Board of Directors
[ Fri, Oct 14th 2011 ] - Market Wire
New Data on Tevaa?s Copaxone® and Laquinimod to Be Highlighted at ECTRIMS/ACTRIMS
[ Fri, Oct 14th 2011 ] - Market Wire
Dynavax to Present at Newsmakers in the Biotech Industry Conference
[ Fri, Oct 14th 2011 ] - Market Wire
MSA Completes Sale of North Carolina Ballistic Vest Business
[ Fri, Oct 14th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Stereotaxis, Inc.
[ Fri, Oct 14th 2011 ] - Market Wire
Teva Completes Acquisition of Cephalon
[ Fri, Oct 14th 2011 ] - Market Wire
Brookwater Announces Hiring of One of the Largest .. physical &;; Geological Teams in Brazil
[ Fri, Oct 14th 2011 ] - Market Wire
Funding Security Critical to Long Term Success of Biotech Firms
[ Fri, Oct 14th 2011 ] - Market Wire
Skanska Awarded R&D Lab Renovation Contract for USD 80 M, About SEK 512 M
[ Fri, Oct 14th 2011 ] - Market Wire
Columbia Laboratories to Present October 21st at NewsMakers in the Biotech Industry Conference

Columbia Laboratories to Present October 21st at NewsMakers in the Biotech Industry Conference


Published on 2011-10-14 04:05:24 - Market Wire
  Print publication without navigation


LIVINGSTON, N.J.--([ BUSINESS WIRE ])--Columbia Laboratories Inc. (Nasdaq: CBRX) announced today that Lawrence A. Gyenes, Senior Vice President, Chief Financial Officer and Treasurer will present at the 18th Annual NewsMakers in the Biotech Industry Conference. The presentation is scheduled as follows:

Date: Friday, October 21, 2011
Time: 2:30-2:55pm ET
Location: Millennium Broadway Hotel and Conference Center, New York, NY

Live webcast:

[ www.columbialabs.com ] in aEventsa™ under the aInvestorsa™ tab

The archived webcast will be available for three months on the Companya™s investor website, [ www.columbialabs.com ], in the aEventsa™ section under the aInvestorsa™ tab.

About Columbia Laboratories

Columbia Laboratories, Inc. is developing products that utilize its novel bioadhesive drug delivery technologies to optimize drug delivery in a controlled, sustained manner. For more information, please visit [ www.columbialabs.com ].

Contributing Sources